Clinical guidelines, for the purposes of a drug management program under 423.153, are criteria -
(1) To identify potential at-risk beneficiaries who may be determined to be at-risk beneficiaries under such programs; and
(2) That are developed in accordance with the standards in § 423.153(f)(16) and, beginning with contract year 2020, will be published in guidance annually.
42 CFR § 423.100
As used in this part, unless otherwise specified-